Researchers observed that co-existing mental health conditions like depression, along with emotional regulation and impulse control challenges, may contribute to elevated suicide rates among people with ADHD.

Overview Debates Related claims Topics Sources

Childhood trauma leads people to develop psychosis

In 2022, mental health inpatient Sophie Alderman died after mistakenly believing that the Oxevision camera monitoring system would alert hospital staff to save her.

Sixteen-year-old Elise Sebastian killed herself in 2021 at Essex Partnership University NHS Foundation Trust after hospital staff muted the Oxevision camera monitoring alarm system.

The proposed FY26 budget restructuring includes a $1 billion funding reduction affecting community mental health centers, suicide prevention, and substance use treatment programs.

The President's FY26 budget proposed dissolving the Substance Abuse and Mental Health Services Administration and the Health Resources and Services Administration to consolidate them into a new Administration for a Healthy America.

The Substance Abuse and Mental Health Services Administration reinstated $2 billion in mental health and substance use grants on January 14, 2026, following bipartisan pushback.

On January 13, 2026, the Substance Abuse and Mental Health Services Administration terminated hundreds of grants totaling approximately $2 billion for mental health and substance use disorder services.

Proposed FY26 restructuring threatens Health Resources and Services Administration programs that support mental health professional training and health delivery in underserved communities.

On May 12, 2025, the federal administration announced it would not enforce September 2024 Biden-era mental health parity regulations for insurance providers.

The ERISA Industry Committee legally challenged the September 2024 mental health parity rules, claiming the regulations overstepped administrative authority and raised costs.

More young people need to get their brain scanned

The JAMA Network Open systematic review and meta-analysis evaluated 19 observational studies encompassing nearly 16 million study participants across three continents, with 63.9% of participants being male.

The meta-analysis revealed a 27% increase in natural-cause mortality risk among individuals diagnosed with attention-deficit/hyperactivity disorder compared to those without the condition.

A JAMA Network Open systematic review and meta-analysis led by University College London researchers found that attention-deficit/hyperactivity disorder is associated with a 70% to 71% higher rate of all-cause mortality.

The JAMA Network Open study found that people diagnosed with attention-deficit/hyperactivity disorder face a 89% to 90% higher rate of death by suicide compared to individuals without ADHD.

Natural-cause mortality in ADHD patients is linked to higher rates of cardiovascular disease, diabetes, metabolic disorders, health risk behaviors like smoking and alcohol use, and healthcare access barriers.

The JAMA Network Open meta-analysis showed that individuals with attention-deficit/hyperactivity disorder experience a 55% higher rate of death from intentional or accidental injuries than those without ADHD.

Researchers warned that the apparent 25% mortality reduction associated with ADHD medication is based on only three observational studies, preventing causal conclusions and requiring caution due to potential confounding factors.

Senior author Professor Joshua Stott noted that while ADHD diagnosis rates have risen in recent years, they continue to lag behind actual prevalence, particularly among older age groups facing higher mortality risk.

An analysis of three studies within the JAMA Network Open review found that individuals taking ADHD medication had a 25% lower risk of all-cause mortality compared to untreated individuals.